Researchers describe how chronic inflammation can lead to stomach cancer

November 06, 2008

NEW YORK - A multi-center research team, led by Columbia University Medical Center, has uncovered a major contributor to the cause of stomach cancer - the second leading cause of cancer-related mortality in the world. The team described for the first time, that elevated levels of a single proinflammatory cytokine, an immune system protein called interleukin-1 beta (IL-1β), can start the progression towards stomach cancer. These results are published in the Nov. 4, 2008 issue of Cancer Cell. The researchers hope to use this finding to develop ways to block this process, thereby preventing cancer from developing.

"This study shows that accumulation of IL-1β, which is induced by infection with the bacterium Helicobacter pylori (H. pylori) in the gastrointestinal tract, is a significant contributor to the onset of stomach cancer," said lead author Timothy C. Wang, M.D., chief of the Division of Digestive and Liver Diseases and the Dorothy L. and Daniel H. Silberberg Professor of Medicine at Columbia University College of Physicians and Surgeons. "We show in this study that IL-1β works by activating a type of white blood cell known as myeloid derived suppressor cells (MDSCs), which in our study appeared to be strongly pro-inflammatory. Blocking IL-1β or the myeloid (MDSCs) cells may represent a potential strategy to prevent stomach cancer."

Previous research has shown that stomach cancer is strongly linked to chronic inflammation, and that infection with H. pylori may trigger the chronic inflammation that can lead to malignancy, but it was not known exactly how. While H. pylori infection is extremely prevalent, only a small minority (less than one percent) of infected individuals will, after many years, go onto develop stomach cancer. Previous research had linked H. pylori infection to the overexpression of IL-1β, and the susceptibility to gastric cancer to high-expressing IL-1 genotypes [Nature 2000;404:398-404], so Dr. Wang and his research team developed a transgenic mouse model in order to investigate the specific role of IL-1β in gastric carcinogenesis.

Results demonstrated that the overexpression of IL-1β in the stomach mobilizes the recruitment of MDSCs - initiating the progression of gastric inflammation into cancer. Furthermore, these findings help to explain why only a small percentage of those with H. pylori infection go onto develop stomach cancer - a genetic predisposition for high expression levels of proinflammatory cytokines.

Stomach Cancer is One of the Most Deadly & Common Cancers Worldwide

Stomach (gastric) cancer is the second (after lung cancer) most common cause of cancer-related mortality worldwide with 900,000 deaths this year. Stomach cancer is much more common in South America, Japan, Korea and Iceland than in the United States, which represents just two percent (25,500) cases of all new stomach cancer diagnosed yearly. It is associated with a diet that is high in salt and low in fruits and vegetables, as well as with smoking, and is more common in men. Infection with the bacterium Helicobacter pylori (H. pylori) is the main risk factor in about 80 percent or more of stomach cancers.

H. pylori is typically acquired in childhood through person to person transmission, and the bacterium lives within the stomach just above the stomach cells, where it induces a mild inflammatory response known as gastritis. H. pylori infection is generally associated with low socioeconomic status and poor hygiene. New H. pylori infection is gradually disappearing from most industrialized countries such as the United States and is now seen predominantly in underdeveloped countries, particularly in Asia and South America. H. pylori infection can lead to both stomach cancer and stomach ulcers but in the vast majority (more than 80 percent) of infected people, it causes no health problems.

Columbia University Medical Center

---

---

	John Hopkins Patients' Guide to Cancer of the Stomach and Esophagus (Johns Hopkins Medicine) by Mark D. Duncan (Author) Johns Hopkins Patients' Guide to Cancer of the Stomach and Esophagus is a concise, easy-to-follow how to guide that puts you on a path to wellness by explaining stomach and liver cancer treatment from start to finish. It guides you through the overwhelming maze of treatment decisions, simplifies the complicated schedule that lies ahead, and performs the task of putting together your plan of care in everyday terms. Empower yourself with accurate, understandable information that will give you the ability to confidently participate in the decision making about your care and treatment.
	100 Q&A About Gastric Cancer (100 Questions & Answers about . . .) by Manish A. Shah (Author) About 21,700 Americans are diagnosed with stomach cancer each year and it occurs most often in people in their 60s and 70s. Whether you're a newly diagnosed patient with gastric cancer or a friend or relative of someone with cancer, this book offers help. This book is an invaluable resource for anyone coping with the physical and emotional turmoil of this disease. The author Dr. Shah is from Memorial Sloan-Kettering Cancer Center, one of the few National Cancer Institute-designated cancer centers with a specific program in treating cancers of the upper gastrointestinal tract and has made many of the major advances in the treatment of these diseases.
	Stomach Cancer: Your Way Forward by Abaco Publishing You will never cure anything if you don’t do something about the underlying cause. This applies to every illness including stomach cancer. In my book ‘Stomach Cancer – Your Way Forward’ I explain why it may have developed, giving you something to do to change the underlying causes and bring things under control. It is almost definitely associated with the organism Helicobacter pylori, associated with bad eating habits, a poor immune system, infections, too many antibiotics, toxic chemicals, geopathic stress and certainly stresses of everyday life affecting your emotions. When cancer declares itself, it could have been developing for ten or fifteen years. All of this is explained to you in detail as though you are with me in my consulting room. I then give ideas on how to change...
	What You Always Wanted To Know About Stomach Cancer by Jazzybee Publishing "What You Always Wanted To Know About..." are fully researched, straight-to-the-point, easily understandable and most comprehensive medical ebooks and guides for everybody. Whether you are just interested in the topic of the book or you are directly affected by it, these books can really help you with the information you need. All books including interactive tables-of-contents, this is your step toward new insights and informations. The contents of this book: General Information About Stomach (Gastric) Cancer Stages of Gastric Cancer Stage 0 (Carcinoma in Situ) Stage I Stage II Stage III Stage IV Recurrent Gastric Cancer Treatment Option Overview Surgery Chemotherapy Radiation...
	Breast Cancer and Iodine : How to Prevent and How to Survive Breast Cancer by Ph.D. Dr. David Derry M.D. (Author) This book is about cause, prevention and treatment of breast cancer. Breast cancer has two phases. The first one, from abnormal cells up to carcinoma in situ reverses with iodine. The second phase, invasion, is controlled by connective tissue thyroid hormone.
	Advances in Surgical Pathology: Gastric Cancer by Dongfeng Tan (Editor), Gregory Lauwers (Editor) Advances in Surgical Pathology: Gastric Cancer provides a concise, updated review of the pathological characteristics of gastric cancer, with an emphasis on exploring practical issues and recent developments. The book features current and emerging concepts in the field of gastric cancer, a disease whose management requires a multidisciplinary approach in which pathology plays a key role. Its six sections cover the essential histopathology of gastric cancer as well as related topics such as imaging evaluation, molecular diagnosis, and personalized treatment, among other areas of interest. Individual chapters written by international experts in the fields of pathology, gastrointestinal medical oncology, cancer epidemiology, and gastrointestinal radiology, address the fundamental issues...
	The Emperor of All Maladies: A Biography of Cancer by Siddhartha Mukherjee (Author) The Emperor of All Maladies is a magnificent, profoundly humane “biography” of cancer—from its first documented appearances thousands of years ago through the epic battles in the twentieth century to cure, control, and conquer it to a radical new understanding of its essence. Physician, researcher, and award-winning science writer, Siddhartha Mukherjee examines cancer with a cellular biologist’s precision, a historian’s perspective, and a biographer’s passion. The result is an astonishingly lucid and eloquent chronicle of a disease humans have lived with—and perished from—for more than five thousand years. The story of cancer is a story of human ingenuity, resilience, and perseverance, but also of hubris, paternalism, and misperception. Mukherjee recounts centuries of...
	American Cancer Society's Guide to Pain Control: Understanding and Managing Cancer Pain by American Cancer Society (Author), Betty Ferrell (Foreword) Effective pain management enables people with cancer to live the lives they want to lead—to eat, sleep, spend time with loved ones, work, pursue hobbies—and this helpful guide explains the many pain-relief options available, including medicines and other methods. Readers will discover how to achieve acceptable pain control and how to understand the optimal balance between pain relief and the potential side effects of pain medications. The book addresses step-by-step ways to describe pain and communicate pain-relief needs; common barriers to pain relief and how to overcome them; and practical tips and strategies for coping with side effects of pain medication.
	Gastric Cancer (Contemporary Issues in Cancer Imaging) by Richard M. Gore (Editor) Gastric adenocarcinoma is the second most common cancer worldwide. It is usually diagnosed at a late stage and prognosis is poor; even with modern diagnostic and treatment methods the 5-year survival is only 10%. Improvements in overall patient survival can only be achieved by earlier diagnosis and by tailored therapeutic strategies based on tumor type, location and stage at presentation. This volume provides a state-of-the-art, integrated diagnostic and therapeutic approach to patient management. The role of the upper GI series, endoscopy, endoscopic ultrasound, MDCT, MRI, and PET/CT in the diagnosis, staging and follow-up of patients with gastric cancer is emphasized. The relative strengths and limitations of these diagnostic examinations will be presented in context with the most...
	Dx/Rx: Upper GI Cancer by Manish A. Shah (Author) Tightly Organized Into A Super-Condensed, Outline Bulleted Format, This Handy, Pocket-Sized Manual Details Precise, Up-To-Date Information For Diagnosis And Treatment Of Esophageal And, Gastric Cancers. Comprehensive And Concise, The Book Covers Epidemiology, Diagnosis, Staging, Treatment, And Complications. Throughout The Handbook, Tables And Figures Summarize Important Clinical Data And Current Professional Society Recommendations, While Salient References Direct Readers To Additional Information. Current, Quick, And Concise, For Instant Access On Ward Or In The Clinic!